Clinical Trials Browser

Phase 1/2 × FCN-437c × Clear all

NCT04488107 2020-07-27

Safety, Tolerability, Pharmacokinetics and Antitumor Activity of FCN-437c

Phase 1/2 Unknown

Breast Neoplasms